spacer
spacer

PDBsum entry 6tmc

Go to PDB code: 
protein ligands metals links
Antibiotic PDB id
6tmc

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
230 a.a.
Ligands
NL5
_OH
IOD
Metals
_ZN ×2
Waters ×278
PDB id:
6tmc
Name: Antibiotic
Title: Vim-2_1dh-triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-beta-lactamases
Structure: Beta-lactamase class b vim-2. Chain: a. Synonym: blavim-2,class b carbapenemase vim-2,metallo beta-lactamase, metallo-beta lactamase protein,metallo-beta-lactamase vim-2,vim-2, vim-2 beta-lactamase,vim-2 class b metallo b-lactamase,vim-2 type metallo-beta-lactamase. Engineered: yes
Source: Pseudomonas aeruginosa. Organism_taxid: 287. Gene: blavim-2, bla vim-2, bla-vim-2, blasvim-2, blavim2, blm, vim- 2, vim-2, paerug_p32_london_17_vim_2_10_11_06255. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
1.40Å     R-factor:   0.158     R-free:   0.168
Authors: H.-K.S.Leiros,T.Christopeit
Key ref: Z.Muhammad et al. (2020). Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases. Bioorg Med Chem, 28, 115598. PubMed id: 32631568 DOI: 10.1016/j.bmc.2020.115598
Date:
04-Dec-19     Release date:   22-Jul-20    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q9K2N0  (Q9K2N0_PSEAI) -  Beta-lactamase from Pseudomonas aeruginosa
Seq:
Struc:
266 a.a.
231 a.a.
Key:    PfamA domain  Secondary structure

 Enzyme reactions 
   Enzyme class: E.C.?
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1016/j.bmc.2020.115598 Bioorg Med Chem 28:115598 (2020)
PubMed id: 32631568  
 
 
Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases.
Z.Muhammad, S.Skagseth, M.Boomgaren, S.Akhter, C.Fröhlich, A.Ismael, T.Christopeit, A.Bayer, H.S.Leiros.
 
  ABSTRACT  
 
Metallo-β-lactamases (MBLs) are an emerging cause of bacterial antibiotic resistance by hydrolysing all classes of β-lactams except monobactams, and the MBLs are not inhibited by clinically available serine-β-lactamase inhibitors. Two of the most commonly encountered MBLs in clinical isolates worldwide - the New Delhi metallo-β-lactamase (NDM-1) and the Verona integron-encoded metallo-β-lactamase (VIM-2) - are included in this study. A series of several NH-1,2,3-triazoles was prepared by a three-step protocol utilizing Banert cascade reaction as the key step. The inhibitor properties were evaluated in biochemical assays against the MBLs VIM-2, NDM-1 and GIM-1, and VIM-2 showed IC50 values down to nanomolar range. High-resolution crystal structures of four inhibitors in complex with VIM-2 revealed hydrogen bonds from the triazole inhibitors to Arg228 and to the backbone of Ala231 or Asn233, along with hydrophobic interactions to Trp87, Phe61 and Tyr67. The inhibitors show reduced MIC in synergy assays with Pseudomonas aeruginosa and Escherichia coli strains harbouring VIM enzymes. The obtained results will be useful for further structural guided design of MBL inhibitors.
 

 

spacer

spacer